Share this page!

Enter URL or ID to Unroll

You can paste full URL like: https://x.com/threadreaderapp/status/1644127596119195649
or just the ID like: 1644127596119195649

How to get URL link on X (Twitter) App

  1. On the Twitter thread, click on or icon on the bottom
  2. Click again on or Share Via icon
  3. Click on Copy Link to Tweet
  4. Paste it above and click "Unroll Thread"!
  5. More info at Twitter Help
Andrew Matzkin Profile picture
@MatzkinHealth
Mar 26, 2020 • 3 tweets • 5 min read • Read on X
If you have any mindshare for non-COVID topics, here's a new article with perspective on where digital therapeutics are today and what needs to happen next to unlock the full potential of #DTX.

pm360online.com/the-next-chapt…
h/t to @dtx_alliance members for helping to inform this perspective, especially @PropellerHealth, which served as a great example for the hypothetical scenario at the start. Thanks especially to @cwhogg, who has been incredibly thoughtful on this topic:

slideshare.net/cwhogg/overcom…
cc-ing other referenced companies and orgs: @CognoaInc @DtheraSciences @Click_Tx @Happify @Pear_Tx @biofourmis @Novartis @sanofi @novonordisk @NoomCoach @AdvaMedUpdate @ExpressScripts @CVSHealth @xealthinc @envoyhealth @Brightinsightco

• • •

Missing some Tweet in this thread? You can try to force a refresh
　

Keep Current with Andrew Matzkin

Andrew Matzkin Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @MatzkinHealth

Andrew Matzkin Profile picture
Sep 16, 2020
Amidst the excitement about consumer wearables, we need to realize how different these models are:

1) Device + algorithm alone
2) Device/algo + your HCP
3) Device/algo + 3rd party coach/HCP

Common tech, but very different biz models, evidence reqs, regulatory, etc.

⬇️THREAD⬇️
1) Device + algo alone:
-Self-Tracking for Fitness/Wellness
-Health Screening (alerts user of a *possible* issue & suggests they see HCP)

-> Can differentiate consumer devices
-> May enable consumer subscription biz
-> May enable device sales to employers and payers
2a) Device/algo + your HCP:
-Remote Patient Monitoring: HCPs track/alerted on specific issues (e.g., adherence, disease exacerbation) to enable early intervention

->Promising clinical/cost impact
-> VERY challenging to get HCPs on board due to reimbursement and workflow concerns
Read 9 tweets
Andrew Matzkin Profile picture
Apr 13, 2020
As anticipated, the virus is accelerating adoption of virtual mental health:
@ginger_io 50% increase March vs. Feb
@Livongo 140% increase for @mystrengthbh March vs. Sept (obv not just due to virus)
@OMadA 10x increase in behav. tools among diabetes patients

1/3
.@omadahealth data point is here:

fiercehealthcare.com/payer/how-covi…

2/3
Broader perspective on the virus' impact on digital health:

healthadvancesblog.com/2020/04/01/how…

3/3
Read 5 tweets
Andrew Matzkin Profile picture
Feb 20, 2020
This @seanduffy editorial will get attention for its POV on DH definitions, but more important is @omadahealth's public affirmation of their strategy to be a Digital Care Provider. Simple way to understand this: they're more likely to compete with @onemedical than @Pear_Tx 1/6
Omada is one of several digital disease management companies (or, now, Digital Care Providers?) organized and licensed as medical practices, along with @Livongo @virtahealth @onduo. Expect many more of these models across different disease areas and patient populations. 2/6
The major differences between these digital disease management companies and innovative primary care models like @iorahealth @goforward and even Amazon Care are 1) how heavily they rely on digital health tech and 2) the innovation of and evidence for their care models 3/6
Read 6 tweets
Andrew Matzkin Profile picture
Jul 24, 2019
Picking up on discussion w/ @chrissyfarr @cwhogg @geoffclapp @malayhgandhi et al. about digital health starting B2C and using that to bridge to B2B2C, this is usually a bad idea, but I think it might work in rare cases. @bloom_life might be such a case 1/5 statnews.com/2019/07/23/pre…
I think the only times this difficult strategy MIGHT work are when there is
1) Real consumer demand around a clinical need AND
2) Clear connection/progression from DTC to clinical version (technology and/or customer acquisition) 2/5
Pregnancy is a great example of a use case that might meet both criteria (though a skeptic would note that @bloom_life's uptake to date has been limited... just 10,000 users and only 50/hours per user). 3/5
Read 5 tweets
Andrew Matzkin Profile picture
Jun 18, 2019
For today's @Google @sanofi deal and January's @Microsoft @Walgreens deal, the headlines are about AI and tech development, with little attention to the part that probably matters much more to the tech co's: winning these co's as cloud customers economictimes.indiatimes.com/news/internati…
Another @Microsoft deal today that looks a lot like these ones, this time with a major health system.
news.microsoft.com/2019/07/08/mic…
Add another tech company/provider deal to this growing list.

statnews.com/2019/09/10/goo…
Read 6 tweets
Andrew Matzkin Profile picture
Jul 25, 2018
.@RebeccaDRobbins' report on @IBMWatson in oncology highlights an important catch-22 for AI algorithms and clinical decision support software...
1/5
The catch-22 for CDS:
•If software makes recommendations that differ from guidelines or what most doctors would recommend, people think the software doesn’t work
•If software always aligns with guidelines or physician consensus, people ask what the value of the software is
2/5
There are (at least) two solutions to this catch 22.
1) Even if the software just recommends what’s in the guidelines or physician consensus, that can have value by saving clinicians time and by expanding access to specialty knowledge (especially in developing markets) 3/5
Read 5 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

Send Email!

:(